Axa’s Viavi Solutions VIAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,027,976
Closed -$10.8M 1192
2022
Q4
$10.8M Sell
1,027,976
-887,777
-46% -$10.7M 0.04% 422
2022
Q3
$25M Sell
1,915,753
-790,444
-29% -$11.3M 0.1% 242
2022
Q2
$35.8M Sell
2,706,197
-101,408
-4% -$1.46M 0.13% 176
2022
Q1
$45.1M Sell
2,807,605
-1,027,417
-27% -$16.9M 0.13% 180
2021
Q4
$67.6M Buy
3,835,022
+26,030
+0.7% +$413K 0.17% 146
2021
Q3
$60M Buy
3,808,992
+22,379
+0.6% +$367K 0.17% 155
2021
Q2
$66.9M Buy
3,786,613
+437,159
+13% +$7.38M 0.19% 129
2021
Q1
$52.6M Buy
3,349,454
+1,759,331
+111% +$28.4M 0.16% 152
2020
Q4
$23.8M Buy
+1,590,123
New +$21.1M 0.07% 291
2013
Q3
Sell
-404,340
Closed -$3.31M 1323
2013
Q2
$3.31M Buy
+404,340
New +$3.13M 0.02% 579

Other funds holding VIAV

Axa's VIAV Position: Q1 2023 in Review

Axa sold out of Viavi Solutions (VIAV) in Q1 2023, closing a stake of 1,027,976 shares — an estimated $10.8M sold.

Axa first reported a position in VIAV in Q2 2013 and held it in 10 quarters. The position peaked at $67.6M in Q4 2021. 303 funds tracked by Wall St. Rank hold VIAV as of Q1 2023.

  • Axa reported no remaining Viavi Solutions position as of Q1 2023 after selling out during the quarter.
  • Axa sold 1,027,976 Viavi Solutions shares in Q1 2023, an estimated $10.8M.
  • Axa first reported a position in Viavi Solutions in Q2 2013 and held it in 10 quarters.
  • Axa's Viavi Solutions position peaked at $67.6M in Q4 2021.
  • 303 funds tracked by Wall St. Rank held Viavi Solutions as of Q1 2023.

Based on Axa's 13F filing for Q1 2023, filed 15 May 2023.